首页> 外文会议>IEEE International Conference on Fuzzy Systems >Mass spectrometry-based proteomic data for cancer diagnosis using interval type-2 fuzzy system
【24h】

Mass spectrometry-based proteomic data for cancer diagnosis using interval type-2 fuzzy system

机译:基于质谱的蛋白质组学数据用于区间2型模糊系统的癌症诊断

获取原文

摘要

An interval type-2 fuzzy logic system is introduced for cancer diagnosis using mass spectrometry-based proteomic data. The fuzzy system is incorporated with a feature extraction procedure that combines wavelet transform and Wilcoxon ranking test. The proposed feature extraction generates feature sets that serve as inputs to the type-2 fuzzy classifier. Uncertainty, noise and outliers that are common in the proteomic data motivate the use of type-2 fuzzy system. Tabu search is applied for structure learning of the fuzzy classifier. Experiments are performed using two benchmark proteomic datasets for the prediction of ovarian and pancreatic cancer. The dominance of the suggested feature extraction as well as type-2 fuzzy classifier against their competing methods is showcased through experimental results. The proposed approach therefore is helpful to clinicians and practitioners as it can be implemented as a medical decision support system in practice.
机译:引入了区间2型模糊逻辑系统,用于使用基于质谱的蛋白质组学数据进行癌症诊断。模糊系统结合了特征提取过程,该过程结合了小波变换和Wilcoxon等级检验。提出的特征提取将生成特征集,这些特征集将作为类型2模糊分类器的输入。蛋白质组数据中常见的不确定性,噪声和异常值促使使用2型模糊系统。禁忌搜索用于模糊分类器的结构学习。实验使用两个基准蛋白质组学数据集进行,以预测卵巢癌和胰腺癌。通过实验结果显示了建议的特征提取以及类型2模糊分类器相对于它们的竞争方法的优势。因此,所提出的方法对临床医生和从业者是有帮助的,因为它可以在实践中作为医学决策支持系统来实施。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号